CYNTHIA BOGGINS: Open Payments
NPI 1285295980 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 19 payments from 9 companies in 2025. Trend: 2023 $97 · 2024 $547 · 2025 $654
Food & beverage: $555Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $415 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Lilly USA, LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| ARRAY BIOPHARMA INC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: RYBREVANT, IMFINZI, OPDUALAG, KEYTRUDA, VERZENIO, Nubeqa, MONOFERRIC, WELIREG.
Industry payments across OH — which companies pay providers there.
